Get More Help in Nevada
Professor of Pediatrics
Chair, Clinical Care Advisory Board of the Children’s Tumor Foundation (national NF support organization)
Chair, Utah State Department of Health Genetic Advisory Committee
Member, Advisory Board for the Mucopolysaccharidosis I Registry
Member, Professional Advisory Board for the Tuberous Sclerosis Alliance
Division of Pediatric Genetics
Department of Pediatrics
University of Utah Health Sciences Center
Salt Lake City, UT 84132
https://healthcare.utah.edu/find-a-doctor/david-h-viskochil#tabAcademic...
Dr. Visckochil’s research has focused on the molecular genetics of the neurofibromatosis type 1 (NF1) gene and bone health and malignancy in patients with NF1. He performs translational research in NF1-related manifestations, and is the Utah principal investigator for the NF Clinical Trials Consortium.
Declared conflicts of interest on file (09/22/2022)
Viskochil DH.
Neurofibromatosis Type 1, 4th edition.
Management of Genetic Syndromes, 4th Edition. ISBN: 978-1-119-43267-8. 2021; 629. New York: Wiley-Blackwell
Excellent review of NF1 by an expert in the field. The book has chapters for 63 different medical conditions and is a great
resource for medical home clinicians.
Viskochil D.
Genetics of neurofibromatosis 1 and the NF1 gene.
J Child Neurol.
2002;17(8):562-70; 571-2, 646-51.
PubMed abstract
Johnson BA, MacWilliams BA, Carey JC, Viskochil DH, D'Astous JL, Stevenson DA.
Motor proficiency in children with neurofibromatosis type 1.
Pediatr Phys Ther.
2010;22(4):344-8.
PubMed abstract / Full Text
Thompson HL, Viskochil DH, Stevenson DA, Chapman KL.
Speech-language characteristics of children with neurofibromatosis type 1.
Am J Med Genet A.
2010;152A(2):284-90.
PubMed abstract
Gottfried ON, Viskochil DH, Couldwell WT.
Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.
Neurosurg Focus.
2010;28(1):E8.
PubMed abstract